OLAPLEX HOLDINGS, INC.
OLPXNasdaqConsumer Staples · Perfumes, Cosmetics & Other Toilet Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $423.0M | $422.7M | $458.3M | $704.3M | $598.4M | $282.3M |
| Operating income | $7.0M | $66.9M | $108.2M | $364.4M | $334.2M | $86.1M |
| Net income | −$9.3M | $19.5M | $61.6M | $244.1M | $220.8M | $39.3M |
| Total assets | $1.50B | $1.77B | $1.74B | $1.70B | $1.56B | $1.33B |
| Total liabilities | $618.1M | $893.3M | $895.4M | $916.7M | $1.04B | $802.2M |
| Equity | $879.4M | $874.4M | $845.0M | $781.0M | $524.3M | $530.7M |
| EPS (diluted) | $-0.01 | $0.03 | $0.09 | $0.35 | $0.32 | $0.06 |
| Shares out. | 664.6M | 660.8M | 651.9M | 648.8M | 648.1M | 647.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 1.6%
- Net margin
- −2.2%
- Return on equity
- −1.1%
- Return on assets
- −0.6%
- Return on capital (ROCE)
- 0.5%
- Liabilities / assets
- 41.3%
- Debt / equity
- 0.70×
- Book value / share
- $1.32
- Revenue growth (YoY)
- 0.1%
- Net income growth (YoY)
- −147.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 4.30safe
- Accruals / assets
- −4.5%clean
- Beneish M-Score
- -1.74elevated
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 6 good- Reported a net loss
- Beneish M-Score elevated — earnings-manipulation screen flag
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7.0M | 2.4 | +12.3% |
| Apr 30, 2026 | 6.2M | 2.0 | -32.2% |
| Apr 15, 2026 | 9.2M | 1.9 | -2.5% |
| Mar 31, 2026 | 9.4M | 1.0 | +6.7% |
| Mar 13, 2026 | 8.8M | 3.2 | +15.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 29, 2026
- Results of operationsMay 11, 2026
- Entered a material agreement · Regulation FD disclosureMar 26, 2026
- Results of operationsMar 5, 2026
- Results of operationsNov 6, 2025
- Entered a material agreement · Regulation FD disclosureAug 26, 2025
- Results of operationsAug 7, 2025
- Director / officer changeJul 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.